Last reviewed · How we verify

NCT06332742

Real-world Evaluation of Qingxin Zishen Decoction on Ovarian Reserve Function Clinical Efficacy in Patients With Decreased

Recruiting now Last updated 4 April 2024
What this trial tests

trial in Decreased Ovarian Reserve in 178 participants. Currently enrolling.

Timeline
1 November 2023
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorYun Chen
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment178
Start date1 November 2023
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across China

Conditions studied

Sponsor

Yun Chen — full company profile →

Who can join

Adults 25 to 45, female only, with Decreased Ovarian Reserve. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective cohort study evaluated the clinical efficacy of Qingxin Zishen Decoction

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Yun Chen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06332742.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing